An innovative, local approach to integrate gestational diabetes diagnosis and treatment into prenatal care for the most vulnerable population.
Although the weeks fly by, I like to stop and appreciate how our industry is making an impact on solving important health issues. Our clients often spearhead philanthropic/social responsibility efforts to support developing markets and tackle global health issues.
Our Accenture Development Partnerships (ADP) team recently teamed up with Novo Nordisk and The World Diabetes Foundation to develop an in-depth case study which describes an ambitious program called Vida Nueva (New Life) to address Gestational Diabetes Mellitus (GDM) in pregnant women. Untreated, GDM has serious consequences for maternal and newborn health, yet receives little attention throughout many developing countries – like Colombia.
Despite a relatively small investment, the Vida Nueva program created tremendous change through a first-of-its-kind, shared value approach with a diverse set of stakeholders: government, private sector, foundations and NGOs, health insurers, provider networks, academics and medical experts. The program created and implemented a new holistic GDM standard of care throughout the public health system. As a result of Vida Nueva in Colombia:
The rate of GDM screening for pregnant women went from 5% to 97% in three years
Increased GDM diagnosis by a factor of 50 (from 0.2 percent in 2012 to nearly 9 percent in 2014)
72% of primary care and OB/GYN personnel were trained within the public health system
4 of 5 pregnant women educated on GDM and healthy living
This program is a model that can be replicated throughout the world to not only address GDM, but many other undertreated conditions.
Accenture Development Partnership (ADP) serves as one mechanism for engaging in these type of programs – lending our experience, expertise and assets to partner with our clients on engagements designed to create better health access for vulnerable people in emerging markets.